Management and research support for the genetic and rare diseases (GARD) information center and related programs

Active Awarded Last action

Contract number
75N95024F00169
Awardee
Awarding agency
Obligated
$7,657,740

Award facts

Opportunity
  • 75N95024Q00565 Solicitation number
Contract value 100% obligated
$7,657,740.00 Current and potential, with all options
Completion date 74% complete
Current and potential, with all options
Set-aside
Woman-Owned Small Business
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Columbia, MD 21046, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 · Ncats - modification to fund the FDA portion of option period two (contract year 3) of the management and research support for the genetic and rare diseases… $85,000
Exercise an Option P00003 · Ncats - modification to exercise option period two (contract year 3) of the management and research support for the genetic and rare diseases (GARD) contract. -… $2,698,351
Exercise an Option P00002 $2,548,663
Supplemental Agreement for work within scope P00001 $0
Original award $2,325,726

About this award

The National Institute on Drug Abuse issued a delivery order to A P Ventures, LLC, a woman-owned small business and SBA 8(a) EDWOSB, on September 29, 2024, under the GSA Multiple Award Schedule for management and research support for the Genetic and Rare Diseases (GARD) Information Center, with a ceiling value of $7.657 million and ultimate completion date of July 28, 2027.

This is a time-and-materials delivery order issued under the woman-owned small business set-aside. Place of performance is Columbia, Maryland. The order funds option period two (contract year 3) of the GARD management and research support effort, with FDA portion funding included in this modification.

Service Contract Inventory reporting shows FY2025 invoicing of $2.3 million across 4.7 FTEs, with all work self-performed by the prime. FY2024 activity included 11 contractor hours with no dollar invoicing recorded.

Quick answers

Who was awarded contract 75N95024F00169?

75N95024F00169 was awarded to A P Ventures, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 29, 2024.

How much is contract 75N95024F00169 worth?

The government has obligated $7,657,740 on 75N95024F00169.

Is contract 75N95024F00169 an order under another contract?

Yes. 75N95024F00169 is a delivery order under GS35F281CA, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75N95024F00169 competed?

The extent of competition for 75N95024F00169 was full and open competition. The government received 2 offers. It was set aside: Woman-Owned Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award